Wegovy Rx Weekly injection pen (semaglutide)

Professional () hero image with (≤42 chars): 'Wegovy Weekly Injection Pen' in crisp white on a deep teal semi-transparent

Last updated: August 10, 2026


Quick Answer: The Wegovy Rx Weekly injection pen (semaglutide) is an FDA-approved once-weekly subcutaneous injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It works by mimicking a natural gut hormone to reduce appetite and slow digestion. As of 2026, a higher-dose 7.2 mg version called Wegovy HD has also been approved in the U.S., UK, and recommended for EU approval, offering greater weight loss than the original 2.4 mg dose.


Key Takeaways

  • The Wegovy Rx Weekly injection pen (semaglutide) is injected once per week, subcutaneously, at doses starting at 0.25 mg and titrating up to 2.4 mg (or 7.2 mg with the new Wegovy HD pen) [4][6]
  • The FDA approved Wegovy HD (semaglutide 7.2 mg) on March 19, 2026, with clinical trial data showing approximately 21% mean weight loss at 72 weeks [6][10]
  • Wegovy and Ozempic both contain semaglutide, but they are FDA-approved for different conditions: Wegovy for weight management, Ozempic for type 2 diabetes
  • Without insurance, Wegovy can cost over $1,300 per month; Novo Nordisk’s savings card may reduce out-of-pocket costs for eligible commercially insured patients [1]
  • Common side effects include nausea, vomiting, diarrhea, and constipation, especially during dose escalation [2]
  • Wegovy is not a short-term fix; stopping it typically leads to weight regain, so long-term use is often necessary
  • Missing a dose by more than five days means skipping that dose entirely and resuming on the next scheduled day [4]
  • Store unused pens in the refrigerator (36°F to 46°F); once opened, a pen can be kept at room temperature for up to 28 days [4]

Editorial () bright studio product hero shot: a single Wegovy semaglutide injection pen centered on a pristine white marble

What Is Wegovy and How Does It Work?

Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for chronic weight management. It works by binding to GLP-1 receptors in the brain and gut, which reduces appetite, increases feelings of fullness, and slows the rate at which the stomach empties food.

GLP-1 is a hormone your body naturally releases after eating. Semaglutide mimics this hormone but lasts much longer in the body, which is why one weekly injection is enough to maintain its effects. The result is a sustained reduction in caloric intake without requiring constant willpower.

Wegovy was first approved by the FDA in June 2021 at a maximum dose of 2.4 mg per week. In March 2026, the FDA approved Wegovy HD at 7.2 mg per week for adults who already tolerate the 2.4 mg dose and need additional weight loss [6]. In the STEP UP trial (72 weeks, 1,407 adults without diabetes), Wegovy HD produced approximately 21% mean weight loss, with 89% of participants achieving at least 5% weight loss compared to 38% on placebo [10].

For a deeper look at how semaglutide works as a weight loss tool, see our semaglutide weight loss injections guide.


Who Is Wegovy Prescribed For?

Wegovy is prescribed for adults who meet specific clinical criteria. It is not a general weight loss aid available to anyone who wants to lose a few pounds.

You qualify for Wegovy if you have:

  • A BMI of 30 kg/m² or higher (obesity), or
  • A BMI of 27 kg/m² or higher (overweight) plus at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol [4][5]

Wegovy is not recommended for people with:

  • A personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • A known allergy to semaglutide or any ingredient in the formulation [4]

Your prescriber will also review your full medical history before prescribing. Wegovy is currently approved for adults; pediatric use (ages 12 and older) has also received FDA approval, though the prescribing criteria differ slightly [5].


Can You Use Wegovy If You Have Diabetes?

Yes, people with type 2 diabetes can use Wegovy, but there are important distinctions from Ozempic, which also contains semaglutide. Wegovy is specifically approved for weight management, while Ozempic is approved for glycemic control in type 2 diabetes. A prescriber may choose Wegovy for a diabetic patient whose primary treatment goal is weight loss.

If you have type 2 diabetes and are already taking insulin or other blood sugar medications, your doctor will need to monitor you closely because semaglutide can lower blood glucose and increase the risk of hypoglycemia when combined with those medications [4].

People with a history of diabetic retinopathy should also discuss risks with their provider, as semaglutide has been associated with worsening of this condition in some cases [4].

For a broader overview of GLP-1 medications in both diabetes and weight loss contexts, our guide on GLP-1 injections for weight loss and diabetes covers the key differences.


Wegovy vs. Ozempic: What Is the Difference?

Wegovy and Ozempic both contain semaglutide, but they are distinct products approved for different medical purposes. This is one of the most common points of confusion for patients.

Feature Wegovy Ozempic
Active ingredient Semaglutide Semaglutide
FDA-approved use Chronic weight management Type 2 diabetes
Maximum dose 2.4 mg/week (7.2 mg with HD) 2.0 mg/week
Injection frequency Once weekly Once weekly
Pen format Pre-filled auto-injector Pre-filled pen with dial

The key practical difference is dosage. Wegovy reaches a higher maintenance dose (2.4 mg, now up to 7.2 mg) than Ozempic (maximum 2.0 mg), which is part of why Wegovy produces greater weight loss in clinical trials. Ozempic is sometimes prescribed off-label for weight loss, but insurance coverage for that use is far less reliable.

If you’re comparing costs between these medications, our GLP-1 price per month comparison breaks down what you’ll actually pay for each option.


How Much Does Wegovy Cost With Insurance?

Without insurance, the list price of Wegovy exceeds $1,300 per month in the U.S. With insurance, your actual cost depends on your specific plan and whether your insurer covers obesity medications, which many do not.

Ways to reduce your cost:

  • Novo Nordisk savings card: Eligible commercially insured patients may pay as little as $0 to $25 per month through Novo Nordisk’s patient savings program [1]
  • Medicare/Medicaid: Federal programs generally do not cover Wegovy for weight loss alone, though coverage for cardiovascular risk reduction indications has expanded
  • Manufacturer patient assistance: Novo Nordisk offers assistance programs for uninsured or underinsured patients who meet income criteria [1]
  • Compounded semaglutide: Now that the FDA has ended the shortage designation for semaglutide, compounded versions face stricter regulatory scrutiny in 2026. See our FDA rules on compounded semaglutide 2026 update for the latest guidance.

For a full breakdown of what Wegovy actually costs across different scenarios, visit our Wegovy cost and semaglutide weight loss pricing guide.


How Much Does Wegovy Cost With Insurance?

How to Use the Wegovy Injection Pen: Step-by-Step

The Wegovy Rx Weekly injection pen (semaglutide) is a pre-filled, single-use auto-injector. You do not need to draw up medication or use a separate needle. Here is how to use it correctly:

Step 1: Prepare

  • Wash your hands thoroughly
  • Remove the pen from the refrigerator and let it reach room temperature for 30 minutes before injecting
  • Check the expiration date and inspect the solution (it should be clear and colorless to slightly yellow)

Step 2: Choose your injection site

  • Inject into the abdomen (at least 2 inches from the navel), the upper thigh, or the upper arm
  • Rotate sites each week to avoid skin irritation
  • Do not inject into skin that is bruised, tender, or scarred

Step 3: Inject

  • Remove the pen cap
  • Press the pen firmly against the skin at a 90-degree angle
  • Press and hold the injection button until you hear a click, then hold for an additional 5 to 10 seconds
  • Remove the pen and dispose of it in a sharps container

Step 4: Record

  • Note the date and injection site in a log or app
  • Set a weekly reminder for the same day each week

For detailed guidance on dosage schedules and escalation timelines, our semaglutide injections dosage guide walks through each titration step.


How Often Do You Inject Wegovy, and What Is the Dose Schedule?

You inject Wegovy once per week, on the same day each week, at any time of day, with or without food [4]. The dose starts low and increases every four weeks to minimize side effects.

Standard Wegovy dose escalation schedule:

Weeks Dose
1-4 0.25 mg/week
5-8 0.5 mg/week
9-12 1.0 mg/week
13-16 1.7 mg/week
17 onward 2.4 mg/week (maintenance)

For Wegovy HD (7.2 mg), the titration continues beyond 2.4 mg for patients who have already tolerated the standard maintenance dose and require additional weight loss [6][8].

The MHRA in the UK confirmed that the maximum weekly dose is 7.2 mg, with titration starting from 0.25 mg per week and increasing every four weeks as clinically appropriate [8].


Wegovy Side Effects: What to Expect

The most common side effects of the Wegovy Rx Weekly injection pen (semaglutide) are gastrointestinal and tend to be most intense during dose escalation. They usually improve as your body adjusts.

Most common side effects [2][4]:

  • Nausea (affects the majority of users, especially in the first weeks)
  • Vomiting
  • Diarrhea
  • Constipation
  • Stomach pain or discomfort
  • Headache
  • Fatigue

Serious but less common side effects to watch for:

  • Pancreatitis (severe abdominal pain radiating to the back)
  • Gallbladder problems, including gallstones
  • Low blood sugar (especially in people also taking insulin or sulfonylureas)
  • Heart rate increase
  • Kidney problems (often related to dehydration from vomiting or diarrhea)
  • Thyroid tumors (observed in animal studies; risk in humans is not established but warrants caution) [4]

Managing nausea: Eating smaller meals, avoiding high-fat or spicy foods, and staying well-hydrated all help. Most patients find nausea improves significantly after the first month at each new dose level.


Wegovy Not Working: Why Am I Not Losing Weight?

Wegovy does not work the same way for everyone, and some patients lose significantly less weight than the clinical trial averages. Several factors can explain this.

Common reasons Wegovy may not be producing expected results:

  • Dose is still too low: The full weight loss effect typically builds over months. Many patients see modest results at lower doses and more significant loss after reaching 2.4 mg
  • Dietary habits haven’t changed: Wegovy reduces appetite, but it does not eliminate the need for a calorie deficit. If you compensate by eating calorie-dense foods, weight loss stalls
  • Insufficient physical activity: Combining semaglutide with regular movement improves outcomes. Our 12-week home workout plan is a practical starting point
  • Medication interactions or underlying conditions: Hypothyroidism, certain medications (like steroids or antidepressants), or insulin resistance can blunt the response
  • Biological non-response: A small percentage of patients are genuine non-responders. If you have been at the maintenance dose for 16 weeks with less than 5% weight loss, discuss alternatives with your prescriber [4]

If you’re not losing weight and wondering whether a higher dose or different formulation might help, our guide on best semaglutide for fat loss compares options.


What Happens If You Miss a Wegovy Injection?

Missing a dose is manageable as long as you follow the right protocol. Do not double up to compensate.

The rule is straightforward [4]:

  • If you miss a dose and the next scheduled dose is more than 5 days away, take the missed dose as soon as you remember
  • If the next scheduled dose is 5 days away or less, skip the missed dose entirely and resume on your regular schedule
  • Never take two doses within 5 days of each other

Missing one dose occasionally will not significantly affect your long-term progress. Missing multiple doses in a row, however, may reduce efficacy and can cause side effects to return when you restart, similar to restarting after a break.


Wegovy Storage and Expiration

Proper storage is essential for maintaining the medication’s effectiveness. Semaglutide degrades if exposed to heat or light.

Storage guidelines [4]:

  • Unopened pens: Store in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze.
  • In-use or opened pens: Can be kept at room temperature (up to 77°F / 25°C) for up to 28 days
  • Light exposure: Keep pens in their original carton to protect from light
  • Expiration: Check the date printed on the pen. Do not use expired medication.
  • Disposal: Use a sharps container. Never dispose of pens in household trash or flush them.

If a pen has been accidentally frozen, do not use it. Contact your pharmacy for a replacement.


Wegovy Storage and Expiration

Is Wegovy Permanent, or Do You Stop Taking It?

Wegovy is not a cure for obesity, and stopping it typically leads to weight regain. Clinical data consistently shows that most patients regain a significant portion of lost weight within one to two years of discontinuing semaglutide.

This is not a failure of the medication. Obesity is a chronic condition with biological drivers, including hormonal and metabolic adaptations that persist after weight loss. Semaglutide addresses these drivers while you take it, but those drivers return when you stop.

What this means practically:

  • Most patients who respond well to Wegovy will need to continue it long-term
  • If cost or side effects require stopping, work with your provider on a tapering plan and a strategy to maintain lifestyle changes
  • Some patients transition to a lower maintenance dose after reaching their goal weight, though this is an evolving area of clinical practice

Wegovy Alternatives: Similar Medications

The Wegovy Rx Weekly injection pen (semaglutide) is one of several GLP-1 and GLP-1/GIP medications now available for weight management. Here is how the main alternatives compare:

Medication Drug class Dosing Key difference
Ozempic (semaglutide) GLP-1 agonist Weekly injection Approved for diabetes; often used off-label for weight loss
Mounjaro / Zepbound (tirzepatide) GLP-1 + GIP agonist Weekly injection Dual mechanism; may produce greater weight loss than semaglutide alone
Saxenda (liraglutide) GLP-1 agonist Daily injection Older GLP-1; less convenient dosing
Oral semaglutide (Rybelsus) GLP-1 agonist Daily pill Same active ingredient as Wegovy; lower bioavailability

For a detailed breakdown of how semaglutide and tirzepatide compare in terms of mechanism and outcomes, see our guide on the difference between semaglutide and tirzepatide.

If cost is the primary concern, our compounded vs. brand semaglutide pros, cons, and costs article covers the trade-offs honestly.


Common Mistakes People Make With Wegovy

Even patients who are motivated and consistent make avoidable errors that reduce results or increase side effects.

The most common mistakes:

  1. Injecting into the same site repeatedly. This causes lipohypertrophy (fatty lumps under the skin) that impairs absorption. Rotate sites every week.
  2. Skipping the dose escalation schedule. Moving up doses faster than prescribed dramatically increases nausea and vomiting. Follow the 4-week intervals.
  3. Expecting rapid results. Wegovy is not a fast drug. Most meaningful weight loss occurs after month three or four. Impatience leads to early discontinuation.
  4. Storing the pen incorrectly. Leaving pens in a hot car or on a sunny windowsill degrades the medication. Always follow storage guidelines.
  5. Not adjusting diet. Some patients assume the appetite suppression will do all the work. Pairing Wegovy with a structured eating approach consistently outperforms medication alone.
  6. Stopping abruptly without a plan. Discontinuing without a provider-guided strategy leads to rapid weight regain and can be emotionally discouraging.

Conclusion

The Wegovy Rx Weekly injection pen (semaglutide) is one of the most clinically validated tools available for chronic weight management in 2026. With the new Wegovy HD 7.2 mg pen now approved in the U.S. and UK and recommended for EU approval, patients who have already reached the 2.4 mg maintenance dose have a clear pathway to even greater weight loss outcomes [6][8][9].

Actionable next steps:

  • Talk to your provider about whether you meet the BMI and clinical criteria for Wegovy
  • Review the cost and coverage situation for your specific insurance plan using our Wegovy cost and semaglutide pricing guide
  • If brand-name Wegovy is out of reach financially, explore whether compounded alternatives are still a legal option in your state via our FDA rules on compounded semaglutide 2026 update
  • Commit to the full dose escalation schedule and pair the medication with dietary and activity changes for the best outcomes

Frequently Asked Questions

Can I change the day I take my weekly Wegovy injection?
Yes. You can change your injection day as long as the new dose is at least five days after your last injection. After that adjustment, continue on the new day each week [4].

Does Wegovy require a prescription?
Yes. Wegovy is a prescription-only medication in the U.S., UK, and EU. You must be evaluated by a licensed healthcare provider who determines you meet the clinical criteria before it can be dispensed.

Can I inject Wegovy in my upper arm?
Yes. The approved injection sites are the abdomen (at least 2 inches from the navel), the upper thigh, and the upper arm. Rotate among these sites each week to prevent skin reactions [4].

How long does it take to see weight loss results with Wegovy?
Most patients see meaningful weight loss beginning around weeks 8 to 12, after reaching higher dose levels. The full benefit at the 2.4 mg maintenance dose typically becomes apparent after four to six months of consistent use.

What should I do if I experience severe nausea?
Eat smaller, blander meals and stay hydrated. If nausea is severe or persistent, contact your provider. They may slow your dose escalation schedule. Do not stop the medication without guidance.

Is Wegovy covered by Medicare?
As of 2026, Medicare Part D coverage for Wegovy for weight loss alone remains limited. However, coverage for cardiovascular risk reduction in patients with established cardiovascular disease has expanded following updated FDA labeling. Check with your specific plan.

Can I take Wegovy while pregnant?
No. Wegovy should be discontinued at least two months before a planned pregnancy. If you become pregnant while taking Wegovy, stop the medication and contact your provider immediately [4].

What is the difference between Wegovy and Wegovy HD?
Wegovy HD is a higher-dose formulation of semaglutide at 7.2 mg per week, approved by the FDA in March 2026. It is intended for adults who already tolerate the standard 2.4 mg dose and need additional weight loss. Wegovy HD produced approximately 21% mean weight loss at 72 weeks in the STEP UP trial [6][10].

Does Wegovy affect alcohol tolerance?
Semaglutide slows gastric emptying, which can affect how quickly alcohol is absorbed. Many patients report increased sensitivity to alcohol. There is no absolute contraindication, but moderation is advisable.

Can I use a GoodRx coupon for Wegovy?
GoodRx coupons are generally not stackable with manufacturer savings cards. For patients without insurance, comparing discount programs is worthwhile. Our guide on GoodRx and semaglutide prescription options with no insurance covers this in detail.


References

[1] What To Pay For Wegovy – https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html

[2] Wegovy – https://www.drugs.com/wegovy.html

[4] Wegovy Prescribing Information – https://www.novo-pi.com/wegovy.pdf

[5] FDA Label 215256s024 – https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf

[6] FDA Approves Fourth Product Under National Priority Voucher Program Higher Dose Semaglutide – https://www.fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide

[8] Single Dose 7.2mg Semaglutide Wegovy Pen Approved To Treat Adult Patients With Obesity – https://www.gov.uk/government/news/single-dose-72mg-semaglutide-wegovy-pen-approved-to-treat-adult-patients-with-obesity

[9] Novo Nordisk CHMP Recommends EU Approval – https://finance.yahoo.com/sectors/healthcare/articles/novo-nordisk-chmp-recommends-eu-173000821.html

[10] FDA Approves Novo Nordisk’s New Wegovy HD Injection – https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-new-wegovy-hd-injection-delivering-the-highest-weight-loss-to-date-for-a-wegovy-injection-adding-to-its-already-expansive-clinical-profile-302718982.html


Similar Posts